{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:15Z","timestamp":1789588395899,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-070"],"award-info":[{"award-number":["2021-I2M-1-070"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022-I2M-1-016"],"award-info":[{"award-number":["2022-I2M-1-016"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022-I2M-2-002"],"award-info":[{"award-number":["2022-I2M-2-002"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022-I2M-JB-012"],"award-info":[{"award-number":["2022-I2M-JB-012"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011238","name":"State Key Laboratory of Phytochemistry and Plant Resources in West China","doi-asserted-by":"publisher","award":["P2022-KF01"],"award-info":[{"award-number":["P2022-KF01"]}],"id":[{"id":"10.13039\/501100011238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jep.2023.117238","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T06:23:00Z","timestamp":1695795780000},"page":"117238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"P2","title":["Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4761-4440","authenticated-orcid":false,"given":"Xiaolei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jep.2023.117238_bib1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/jcb.27102","article-title":"Berberrubine and its analog, hydroxypropyl-berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol-lowering effects in human hepatoma HepG2 cells","volume":"120","author":"Cao","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jep.2023.117238_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","article-title":"Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease","volume":"14","author":"Chang","year":"2016","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.jep.2023.117238_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56235-y","article-title":"FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis","volume":"9","author":"Coilly","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jep.2023.117238_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","article-title":"From fat to inflammation","volume":"130","author":"Day","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jep.2023.117238_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/gut.2006.091967","article-title":"A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations","volume":"55","author":"Federico","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jep.2023.117238_bib6","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.2147\/DDDT.S386982","article-title":"Biological mechanisms and related natural inhibitors of CD36 in nonalcoholic fatty liver","volume":"16","author":"Feng","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"issue":"5","key":"10.1016\/j.jep.2023.117238_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/01480545.2019.1601736","article-title":"Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats","volume":"44","author":"Ferreira","year":"2019","journal-title":"Drug Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.jep.2023.117238_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1142\/S0192415X10008548","article-title":"Effects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL","volume":"38","author":"Guan","year":"2010","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.jep.2023.117238_bib9","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/s41467-020-18565-8","article-title":"CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis","volume":"11","author":"Hao","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jep.2023.117238_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3892\/mmr.2012.1236","article-title":"Berberine-attenuated monocyte adhesion to endothelial cells induced by oxidized low-density lipoprotein via inhibition of adhesion molecule expression","volume":"7","author":"Huang","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.jep.2023.117238_bib11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ptr.1988","article-title":"The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Huseini","year":"2006","journal-title":"Phytother Res."},{"issue":"12","key":"10.1016\/j.jep.2023.117238_bib12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2023.117238_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of berberine: an update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2023.117238_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.jep.2023.117238_bib15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/pharmaceutics12090882","article-title":"Enhanced intestinal absorption and pharmacokinetic modulation of berberine and its metabolites through the inhibition of p-glycoprotein and intestinal metabolism in rats using a berberine mixed micelle formulation","volume":"12","author":"Kwon","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jep.2023.117238_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2014.09.049","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension","volume":"161","author":"Lan","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.117238_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"issue":"18","key":"10.1016\/j.jep.2023.117238_bib18","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3748\/wjg.v17.i18.2288","article-title":"Silybin and the liver: from basic research to clinical practice","volume":"17","author":"Loguercio","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.jep.2023.117238_bib19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","article-title":"Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"52","author":"Loguercio","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.jep.2023.117238_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.jep.2023.117238_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.apsb.2020.03.005","article-title":"Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe(-\/-) mice","volume":"10","author":"Ma","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jep.2023.117238_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.jep.2023.117238_bib23","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1016\/S0021-9258(19)50107-7","article-title":"Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver","volume":"267","author":"Ntambi","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2023.117238_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/641597","article-title":"Hepatoprotective effects of Silybum marianum (silymarin) and Glycyrrhiza glabra (glycyrrhizin) in combination: a possible synergy","volume":"2014","author":"Rasool","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4\u20136","key":"10.1016\/j.jep.2023.117238_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.plefa.2010.02.029","article-title":"Fatty acid transport across the cell membrane: regulation by fatty acid transporters","volume":"82","author":"Schwenk","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"3","key":"10.1016\/j.jep.2023.117238_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/jpet.109.161612","article-title":"A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis","volume":"332","author":"Serviddio","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.jep.2023.117238_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104941","article-title":"Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis","volume":"9","author":"Sesti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2023.117238_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110785","article-title":"The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling","volume":"131","author":"Shabalala","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2023.117238_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/169216","article-title":"Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study","volume":"2014","author":"Stiuso","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"10","key":"10.1016\/j.jep.2023.117238_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/nu9101052","article-title":"Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease","volume":"9","author":"Suarez","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jep.2023.117238_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jep.2023.117238_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/pharmaceutics13030306","article-title":"Co-Delivery of berberine chloride and tariquidar in nanoliposomes enhanced intracellular berberine chloride in a doxorubicin-resistant K562 cell line due to p-gp overexpression","volume":"13","author":"Vanti","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jep.2023.117238_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14218\/JCTH.2016.00061","article-title":"Perspectives on nonalcoholic fatty liver disease: an overview of present and future therapies","volume":"5","author":"Vizuete","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"10.1016\/j.jep.2023.117238_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cells10020210","article-title":"Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jep.2023.117238_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3593951","article-title":"The therapeutic effect of berberine in the treatment of nonalcoholic fatty liver disease: a Meta-Analysis","volume":"2016","author":"Wei","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.jep.2023.117238_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.jep.2023.117238_bib37","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.3390\/nu7115454","article-title":"Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance","volume":"7","author":"Yki-Jarvinen","year":"2015","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.jep.2023.117238_bib38","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/A:1025044913766","article-title":"Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells","volume":"20","author":"Zhang","year":"2003","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"8","key":"10.1016\/j.jep.2023.117238_bib39","article-title":"Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jep.2023.117238_bib40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.intimp.2013.08.019","article-title":"Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1\/PI3K\/Akt pathway","volume":"17","author":"Zhang","year":"2013","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.jep.2023.117238_bib41","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/ncomms6493","article-title":"Berberine activates thermogenesis in white and brown adipose tissue","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jep.2023.117238_bib42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/dmd.121.000438","article-title":"Silybin restored CYP3A expression through the sirtuin 2\/nuclear factor \u03ba-B pathway in mouse nonalcoholic fatty liver disease","volume":"49","author":"Zhang","year":"2021","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.jep.2023.117238_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2017.11.023","article-title":"Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe(-\/-) mice","volume":"268","author":"Zhu","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037887412301108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037887412301108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:16:16Z","timestamp":1736403376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037887412301108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"alternative-id":["S037887412301108X"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2023.117238","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine-silybin salt achieves improved anti-nonalcoholic fatty liver disease effect through regulating lipid metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2023.117238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117238"}}